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Background: We determined the prevalence and evidence for physical linkage amongst integrons, insertion
sequences, Tn21 and Tn7 transposons in a collection of 1327 E. coli obtained over a 19-year period from patients
in Kenya.
Results: The prevalence of class 1 integrons was 35%, class 2 integrons were detected in 3 isolates but no isolate
contained a class 3 integron. Integron lacking the 3’-CS or those linked to sul3 gene or IS26 or those containing the
ISCR1 were only detected in multidrug resistant (MDR) strains. The dfrAs were the most common cassettes and their
prevalence was: - dfrA1(28%), dfrA12(20%), dfA17(9%), dfrA7(9%), and dfrA16(5%). The aadA were the second most
abundant cassettes and their prevalence was: - aadA1(25%), aadA2(21%), and aadA5(14%). Other cassettes occurred
in lower prevalence of below 5%. Prevalence of Tn21, ISEcp1, ISCR1 and IS26 was 22%, 10%, 15%, and 7%
respectively. Majority of Tn21 containing integrons carried a complete set of transposition genes while class 2
integrons were borne on Tn7 transposon. The qnrA genes were detected in 34(3%) isolates while 19(1%) carried
qnrB. All qnr genes were in MDR strains carrying integrons containing the ISCR1. Close to 88% of blaTEM-52 were
linked to IS26 while ≥ 80% of blaCTX-Ms and blaCMYs were linked to ISEcp1. Only a few studies have identified a
blaCTX-M-9 containing an ISEcp1 element as reported in this study. Multiple genetic elements, especially those borne
on incIl, incFII, and incL/M plasmids, and their associated resistance genes were transferrable en bloc to E. coli strain
J53 in mating experiments.
Conclusions: This is the first detailed study on the prevalence of selected elements implicated in evolution of
resistance determinants in a large collection of clinical E. coli in Africa. Proliferation of such strains carrying multiple
resistance elements is likely to compromise the use of affordable and available treatment options for majority of
poor patients in Africa. There is therefore a need to monitor the spread of these highly resistant strains in
developing countries through proper infection control and appropriate use of antimicrobials.* Correspondence: jndemi@yahoo.com
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Recent studies conducted in Kenya show that a significant
proportion of E. coli strains from clinical specimens
exhibit a strong multi-drug resistance (MDR) phenotype
[1,2]. Fortunately, β-lactams, fluoroquinolones and ami-
noglycosides remain effective against a significant propor-
tion of clinical E. coli strains in Kenya. However, recent
studies have reported carriage of plasmid-borne aac(6')-
lb-cr and qnr genes among β-lactamase producers [1,2].
The qnr genes confer resistance to quinolones, while aac
(6')-lb-cr confers reduced susceptibility to fluoroquino-
lones and aminoglycosides. Therefore, carbapenems re-
main some of the few alternative antimicrobials that
are effective against strains harboring a combination of
multiple β-lactamase (bla) genes and genes conferring
broad-spectrum resistance to fluoroquinolones and amino-Table 1 Susceptibility profiles of isolates and their distributio
categories of patients
Distribution [Number
strains in different sp
Number of resistant
strains n = 1327
% of resistant
strains
Stool n = 505 Urine
AMOX 756 57 225 (30) 35
AMP 809 61 253 (31) 37
AMC 478 36 143 (30) 24
AMS 544 41 153 (28) 28
TZP 279 21 85 (30) 14
AZT 385 29 121 (31) 19
CEF 411 31 121 (29) 25
CRO 358 27 97 (27) 18
CTX 372 28 102 (27) 19
CAZ 279 21 83 (30) 14
FEP 119 9 31 (26) 7
FOX 106 8 19 (18) 7
NA 239 18 86 (36) 13
CIP 106 8 19 (18) 7
STRP 491 37 145 (30) 27
K 305 23 85 (28) 16
CN 239 18 71 (30) 13
NEO 212 16 71 (34) 12
F 385 29 89 (23) 25
C 478 36 167 (35) 23
SUL 637 48 189 (30) 35
TET 703 53 218 (31) 35
TRIM 557 42 167 (30) 29
The distribution of resistant strains in different specimen-types obtained from inpat
number of strains resistant to a given antimicrobial in different specimen types and
clavulanic acid, AMS: ampicillin-sulbactam, TZP: piperacillin-tazobactam, AZT: Aztreo
FEP: cefepime, FOX: cefoxitin, NA: nalidixic acid, CIP: ciprofloxacin, STRP: streptomyc
C: chloramphenicol, SUL: sulfamethoxazole, TET: Tetracylines, TRIM: Trimethoprim.glycosides. Carbapenems may however not be readily
available or affordable for many patients in Sub-Saharan
Africa [3].
In a recent study, we reported carriage of integrons, IS
elements, Tn21 and Tn7 in a collection of 27 E. coli
strains obtained from hospitalised patients [1]. These
strains also harbored conjugatively transferrable plasmids
conferring resistance to β-lactams, fluoroquinolones,
aminoglycosides and co-trimoxazole among other antimi-
crobials suggesting that genes encoding resistance to these
antimicrobials are physically linked to each other. Carriage
of physically linked elements, each containing a set of
resistance genes, may increases the chances of en bloc
horizontal transfer of multiple resistance determinants
to susceptible strains. Carriage of multiple resistance
elements may in turn confer unique advantages to then in various specimen-types obtained from different
,%] of resistant
ecimen types
Distribution [Number,%] of resistant
strains according to patient category
n = 451 Blood n = 371 Inpatient n = 654 Outpatient n = 673
5 (57) 176 (23) 439 (58) 318 (42)
3 (46) 184 (23) 518 (64) 292 (36)
9 (52) 86 (18) 329 (69) 148 (31)
8 (53) 103 (19) 343 (63) 201 (37)
1 (51) 53 (19) 226 (81) 53 (19)
1 (50) 73 (19) 258 (67) 127 (33)
6 (62) 34 (8) 234 (57) 177 (43)
4 (51) 78 (22) 266 (74) 93 (26)
7 (53) 73 (19) 290 (78) 82 (22)
2 (51) 54 (19) 201 (72) 78 (28)
6 (64) 12 (10) 99 (83) 20 (17)
9 (74) 8 (6) 87 (82) 19 (18)
2 (55) 21 (9) 163 (68) 77 (32)
9 (75) 8 (8) 65 (61) 41 (39)
1 (55) 75 (15) 290 (59) 201 (41)
7 (55) 53 (17) 195 (64) 110 (36)
1 (54) 37 (16) 170 (71) 69 (29)
0 (56) 21 (10) 174 (82) 38 (18)
4 (66) 42 (11) 277 (72) 108 (28)
3 (49) 78 (16) 320 (67) 158 (33)
6 (56) 92 (14) 440 (69) 197 (31)
3 (50) 132 (19) 478 (68) 225 (32)
0 (52) 100 (18) 379 (68) 178 (32)
ients and outpatients. The percentages are calculated based on the total
category of patients. AMOX: amoxicillin, AMP: ampicillin, AMC: amoxicillin-
nam, CEF: cefuroxime, CRO: ceftriaxone, CTX: cefotaxime, CAZ: ceftazidime,
in, K: kanamycin, CN: gentamicin, NEO: neomycin, F: nitrofurantoin,
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tion pressure especially in hospital settings [4].
Studies to determine the prevalence of resistance ele-
ments in a large collection of strains from Sub-Saharan
Africa are still lacking. Furthermore, little is known on
whether the genetic elements encountered among E. coli
strains in this region are physically linked to each other.
In this study, we determined the prevalence of integrons,
ISEcp1, ISCR1, IS26 as well as transposons Tn21 and
Tn7 in a collection of 1327 E. coli strains obtained from
inpatient and outpatient populations seeking treatment
in Kenyan hospitals during a 19-year period (1992–
2011). We also determined genetic content of integrons
and determined plasmid incompatibility groupings
among strains exhibiting unique resistance phenotypes.
Physical linkages among these elements and to bla genes
were investigated using PCR methods. Similar analysis
were done to determine if the aac(6')-lb-cr and qnr
genes are physically linked to these elements.
Results
Antimicrobial susceptibility profiles
At least 25% of the 1327 isolates were resistant to
expanded-spectrum β-lactams such as aztreonam (AZT),
ceftriaxone (CRO), cefotaxime (CTX) and amoxicillin-
clavulanic acid (AMC) combunation and to none-β-
lactams such as streptomycin (S), nitrofurantoin (F),
chloramphenicol (C), sulfamethoxazole (SUL), tetracy-
clines (TET) and trimethoprim (TRIM), Table 1. Resist-
ance to a combination of two β-lactamase inhibitors,
AMC and pipperacillin-tazobactam (TZP), was recorded
in 22% of the isolates while 20% and 9% exhibited an
ESBL- or an AmpC-like phenotype respectively, Table 2.
A total of 106 strains were resistant to combinations of
SUL, TRIM, ciprofloxacin (CIP), cefepime (FEP), gentami-
cin (CN), cefoxitin (FOX) and TZP. These isolates wereTable 2 Distribution of isolates exhibiting combined resistanc
Total isolates exhibiting
a given phenotype
SUL, TRIM, CIP + CN + FEP + FOX + TZP
and aminoglycosides a
106
F + SUL + TRIM + TET + Cb 451
AMC + AMSc 411
AMS + AMC + TZPc 291
ESBL strains 272
Isolates with an AmpC-like phenotype 122
Distribution of strains resistant to different combinations of antimicrobials among d
ciprofloxacin, CN: gentamicin, FEP: cefepime, FOX: cefoxitin, TET: tetracyclines, TZP:
Trimethoprim, C: chloramphenicol, AMC: amoxicillin-clavulanic, AMS: ampicillin-sulb
ESBL strains are susceptible to AMC and cephamycins but resistant to various comb
resistant to cephalosporins and cephamycins.
a: Isolates were resistant to at least one aminoglycoside.
b: These antimicrobials are relatively cheap and are readily available in developing
c: Combinations of β-lactamase inhibitors that may be used to treat infections caustherefore identified as strains with the highest potential
to limit therapeutic option in clinical settings. Imipenem
(IMI), cefepime FEP and CIP were effective against ≥ 90%
of isolates. Strains from urine were more likely to exhibit
an MDR phenotype compared to those from stool
(p:0.0001, CI:27.2 to 84.8, OR:42) or blood (p:0.0001,
CI:12.8 to 30.8, OR:19.9). Similarly, MDR phenotypes were
more common among strains from hospitalized patients
than those from non-hospitalized patients (p:0.0001,
CI: 4.0 to 6.6, OR:5.1).
Prevalence of integrons and integron cassettes
Class 1 integrons were detected in 35% of all isolates,
3 isolates carried class 2 integrons but none tested posi-
tive for class 3 integrons. The dfrA sub-types conferring
resistance to TRIM and the aadA-type cassettes confer-
ring resistance to aminoglycosides were the most com-
mon cassettes in class 1 and 2 integrons, Table 3. The
prevalence of cassettes encoding resistance to trimetho-
prim was: - dfrA1 (28%), dfrA12 (20%), dfA17 (9%), dfrA7
(9%), and dfrA16 (5%), while that of aadA cassettes con-
ferring resistance to aminoglycosides was as follows:
- aadA1 (25%), aadA2 (21%), and aadA5 (14%). Despite a
relatively high prevalence of resistance to β-lactams, only
blaOXA-1 was identified as an integron cassette. While
aadA and dfrA types were detected in strains exhibiting re-
sistance to between 2 and 8 classes of antimicrobials, dfrB,
aadA5, blaOXA-1, aac(6’)-lb-cr, and arr2 were detected only
in strains resistant to at least 6 different classes of antimi-
crobials. Majority (78%) of dfrA17 were detected in strains
resistant to multiple generations of β-lactams.
The cmlA1 and aadA1/dfrA1 cassette arrays were only
detected in integrons containing a 3’-CS. In contrast, at
least 64% of aac(6')-lb-cr, dfrA12/aadA1/blaoxa1, orf5/
dfrB/orfA, and aac(6')Ib/blaoxa-1/catB3/arr2 cassette ar-
rays were detected in integrons lacking typical 3’-e to selected antimicrobials
Stool Urine Blood Inpatient Outpatient
30 (28) 57 (54) 19 (18) 87 (82) 19 (18)
121 (27) 233 (52) 97 (22) 322 (71) 129 (29)
125 (30) 218 (53) 68 (17) 255 (62) 156 (38)
87 (30) 172 (59) 32 (11) 194 (67) 97 (33)
95 (35) 133 (49) 44 (16) 188 (69) 84 (31)
38 (31) 72 (59) 12 (10) 93 (76) 29 (24)
ifferent specimen-types obtained from inpatient and outpatients. CIP:
piperacillin-tazobactam, F: nitrofurantoin, SUL: sulfamethoxazole, TRIM:
actam.
inations of cephalosporins while isolates with an AmpC-like phenotype are
countries.
ed by strains that are resistant to β-lactams.
Table 3 Diversity of cassette arrays detected among class 1 and class 2 integrons
Distribution [number, (%)] of
cassette arrays of cassette arrays
in different types of integrons
Resistance to selected antimicrobials
in randomly selected strains carrying
a given integron array
Classes of antimicrobials
to which the host strain
was resistanta
Prevalence among isolates
with integrons (n = 464)
Integrons
containing 3’-CS
Integrons
lacking 3’-CS
Class 1 integrons arrays
dfrA1 TRIM, SUL, TET, 2 to 4 60 (13) 53 (88) 7 (12)
dfrA1/aadA1 TRIM, STP, AMP, C, CTX, CAZ, CIP, NA 5 to 8 51 (11) 42 (82) 9 (18)
dfrA17/aadA5 TRIM, STP, C, AMP, C, CTX, CAZ, CIP, NA, FOX, AMC 5 to 8 42 (9) 34 (81) 8 (19)
dfrA7 TRIM, SMX, TET 2 to 8 42 (9) 35 (83) 7 (17)
aadA1 STP, C, TET, SUL 2 to 6 23 (5) 19 (83) 4 (17)
dfrA12/aadB TRIM, STRP, CN, K, TOB, AMP, C, CTX, AMC 4 to 8 23 (5) 19 (83) 4 (17)
dfrA16/aadA2 TRIM, STP, K, TOB, AMP, C, CTX, AMC 6 to 8 23 (5) 22 (96) 1 (4)
aadA2/dfrA12 STP, TRIM, TET, C, SUL, AMP, CTX, AMC, 3 to 6 28 (6) 26 (93) 2 (7)
dfrA12/aadA2 TRIM, STP, TET, C, SUL 3 to 8 23 (5) 22 (96) 1 (4)
aadA5 STP, AMP, SUL, TET 7 to 8 23 (5) 22 (96) 1(4)
blaoxa-1/aadA1 STP, AMP, C, TET, CTX, CAZ, CIP, NA, FOX, AMC 8 23 (5) 22 (94) 1 (4)
blaoxa-1/aadA2 STP, AMP, C, TET, CTX, CAZ, CIP, NA, FOX, AMC 7 to 8 9 (2) 8 (88) 1 (12)
dfrA12/orfF/aadA2 TRIM, STP, C, TET, CTX, NA, AMC 6 to 8 9 (2) 8 (88) 1 (12)
aac(6')Ib/catB1/dfrA1 CN, TOB, C, TRIM, K, AMP, C, TET, CTX, CAZ, CIP, NA, 5 to 8 9 (2) 7 (78) 2 (22)
aadA1/dfrA1 STP, TRIM, AMP, C, TET, CTX, NA, AMC 3 to 8 9 (2) 9 (100) 0
aac(6')Ib/blaoxa-1/catB3/arr2 CN,TOB, K, C, RIF, AMP, C, TET, CTX, CAZ, CIP, NA, FOX, AMC 8 9 (2) 2 (22) 7 (78)
aadA2/orfF/dfrA12 STP, AMP, TRIM, SUL, TET 7 to 8 5 (1) 4 (80) 1 (20)
cmlA1 C,, TET, CTX, NA, AMP 3 to 8 3 (<1) 3 (100) 0
orf5/dfrB/orfA TRIM, CN,TOB, C, AMP, C, TET, CTX, CAZ, CIP, NA, AMC 6 3 (<1) 0 3 (100)
dfrA12/aadA1/blaoxa1 TRIM, STP, CN,TOB, AMP, C, TET, CTX, CAZ, CIP, NA, 8 5 (1) 0 5 (100)
aac(6')-lb-cr CN, K, TOB, C, AMP, C, TET, CTX, CAZ, CIP, NA, AMC 8 42 (9) 15 (36) 27 (64)
Class 2 Integron arrays
drfA1/sat2/aadA1 TRIM, STRP, CN, K, TOB, AMP, C, CTX, AMC 6 to 8 3 (<1) NA NA
The integron cassette arrays are indicated in the order they appear within class 1 and 2 integron variable cassette region (in the 5’-3’ orientation).
The resistance phenotype associated with a given array is indicated in bold.
a: Different antimicrobials tested in this study were conveniently grouped into 8 groups:- β-lactams and β-lactamase inhibitors, aminoglycosides, (fluoro)quinolones, nitrofurantoin, chloramphenicol, sulphonamides,
trimethoprim, and tetracyclines.
b: These integrons carried a sul3 gene at the 3’-end or lacked this gene or 3’-CS comprising the qacEΔ1-sul1 genes.
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http://www.biomedcentral.com/1471-2180/13/109conserved sequences (3’-CS) that contains qacEΔ1 (a
truncated gene encoding resistance to quaternary am-
monium compounds, and sul1 encoding resistance to
sulfonamides). All the three class 2 integrons contained
an identical cassette array comprising dfrA1-sat2-aadA1.
Prevalence of Tn21, Tn7 and IS elements
The prevalence of Tn21 was 22% while Tn7 was
detected in 3 isolates that also carried class 2 integrons.
Prevalence of ISEcp1, ISCR1 and IS26 was 10%, 15%,
and 7% respectively. A high proportion (≥ 60%) of isolates
containing the IS elements and integrons were MDR (re-
sistant to at least 3 different classes of antimicrobials),
Table 4. Isolates carrying multiple elements were more
likely to exhibit an MDR phenotype than those lacking such
elements (p:0.0001, CI:549.5 to 2419.6, OR:1153) and iso-
lates from urine were more likely to harbor multiple ele-
ments compared to those from blood (p:0.0001, CI:3.1 to
5.5, OR:4.1) or those from stool (p:0.0008, CI:1.2 to 2.0,
OR:1.6). Although integrons, IS elements and Tn21 were
detected in isolates from all specimen-types, a high propor-
tion (69%) of these elements were detected among strains
from urine of hospitalized patients.
Physical linkage amongst genetic elements
Figure 1 illustrates the strategy used for interrogation for
physical linkages amongst genetic elements while Figure 2
illustrates some of the genetic associations identified in
this study. Majority (69%) of integrons containing 3’-CS
were physically linked to the Tn21 transposon while 75%
of those containing a sul3 gene at the 3’-terminal were
linked to IS26. This element was also linked to 80% of
integrons lacking the 3’-CS, Table 5. Forty (40) isolatesTable 4 Carriage of resistance genetic elements among 1327
antimicrobials
Combinations of genetic elements Isolates positive for
genetic elements
% among
1327 isolate
Integrons 464 35
ISCR1 199 15
ISEcp1 128 10
IS26 86 7
Tn21 289 22
Tn7 3 <1
Combination of genetic elements in same isolate
Integron + ISCR1 + Tn21 38 3
Integron + ISCR1 + IS26 28 2
Integron + ISCR1 + ISEcp1 + Tn21 16 1
No genetic element detected 332 35
Carriage of genetic elements or combination of elements among strains exhibiting
were grouped into 8 convenient groups:- β-lactams and β-lactamase inhibitors, am
sulphonamides, trimethoprim, and tetracyclines.contained class 1 integrons linked to a single IS26 up-
stream the 5’-CS while in 12 isolates the integrons was
flanked by two IS26 elements. All ISCR1 were detected
only in MDR strains and were flanked by a pair of class 1
integron 3’-CS. Close to 94% of Tn21 that were linked to
an integron contained a complete set of transposition
genes (tnpA, tnpR and tnpM) while 89% of Tn21 with an
incomplete set of these genes did not contain an integron,
Table 6. All the three class 2 integrons were physically
linked to Tn7.
Physical linkages between resistance genes and
genetic elements
Figure 2 illustrates selected examples of physical linkages
between bla genes and different genetic elements. Over
40% of isolates carrying blaTEM-52, blaSHV-5 or blaCTX-M-14
were physically linked to the IS26, Table 7. The ISEcp1
was the most common IS element associated with
blaCTX-M-14, blaCTX-M −15 and blaCMY-2. One isolate con-
tained a blaCTX-M-9 linked to this element. In all cases, the
ISEcp1 was detected upstream the bla gene, Figure 2.
Thirty seven (88%) of the 42 aac(6’)-lb-cr were borne
on integrons containing the ISCR1 while 55% were
borne on integrons linked to the IS26. Twenty four
(71%) of the 34 isolates carrying a qnrA gene were resis-
tant to nalidixic acid but not to ciprofloxacin while the
other 10 isolates carrying this gene and 19 carrying the
qnrB subtype were resistant to both antimicrobials,
Table 8. None of the isolates tested positive for qnrS.
Majority (87%) of qnr genes were physically linked to ei-
ther integron-associated ISCR1 or the IS26. All Isolates
carrying aac(6’)-lb-cr or the qnr genes contained mul-
tiple genetic elements and were all MDR.E. coli exhibiting resistance to different classes of
Classes of antimicrobials to which host strains were resistanta
s
0 1 ≤ 2 3 ≤ 5 6-8
0 37 (8) 65 (14) 362 (78)
0 0 18 (9) 181 (91)
0 0 35 (27) 93 (73)
0 0 12 (14) 74 (86)
0 18 (6) 33 (11) 238 (83)
0 0 1 (25) 2 (75)
0 0 2 (5) 36 (95)
0 0 2 (7) 26 (93)
0 0 0 16 (100)
307 (93) 25 (6) 0 0
resistance to different antimicrobials tested in this study. The antimicrobials
inoglycosides, (fluoro)quinolones, nitrofurantoin, chloramphenicol,
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Figure 1 Schematic diagram showing some of the strategies for screening for various genetic elements and for interrogation between
these elements and resistance genes. The targets of each primer and the direction of PCR amplification is shown using arrows. PCRs were
done both in the 5’ and in the 3’ orientation for each pair of genes tested. A: The strategy used for detection and characterization of class 1
integrons. B: The strategy used for detection and characterization of class 2 integrons and their physical linkage to Tn7. C: An example of the
strategy used for analysis of physical linkages between class 1 integrons and Tn21 and to IS26. The primer positions for screening of Tn21
transposition genes. D and E: An example of the strategy used for analysis for physical linkages between integrons, ISCR1 and bla genes. F: An
example of the strategy used for analysis for physical linkages between integrons, ISEcp1, IS26 and bla genes. These illustrations are based on PCR
mapping data and not sequencing. Therefore, the sizes of each gene and the distances between any two genes are not drawn to scale.
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http://www.biomedcentral.com/1471-2180/13/109Conjugative plasmids mediate en bloc transfer of multiple
elements and resistance genes
Multiple resistance genes and genetic elements associated
with them were transferred en bloc to E. coli J53 in mating
experiments, Table 9. Majority of such transferred were
mediated by plasmids containing I1, L/M, XI, HI2 and the
F-type replicons. These experiments further revealed that
genes conferring resistance to tetracylines and chloram-
phenicol were also harbored in the same plasmids encoding
resistance to β-lactams, (fluoro)quinolones and amino-
glycosides. However, various gene combinations that had
been determined to be physically linked using PCR could
not be transferred in conjugation experiments using media
containing different combinations of antimicrobials.
Discussion
The current study shows that a significant proportion of
clinical E. coli strains in Kenyan are resistant to important
classes of antimicrobials such as β-lactams, fluoroquino-
lones and aminoglycosides. These results are in agreementwith those published before [1,3,5]. These MDR strains
were however susceptible to carbapenems. It is easy
(although illegal) to purchase antimicrobials in Kenya with-
out prescriptions or with prescriptions not backed by la-
boratory investigations [6]. We hypothesize that such
practices may directly or indirectly lead to emergence of
highly resistant strains.
A high prevalence of MDR strains from urine and all
specimens from hospitalized patients may reflects a cor-
responding heavy use of antimicrobials among this cat-
egory of patients as reported in past studies [7,8].
Majority of resistances encountered in hospital isolates
were also encountered in community settings probably
because patients are often discharged from hospitals as
soon as their conditions improve, even before they
complete their treatment regiments (our unpublished
observations). It is therefore possible that hospital strains
find their way into community settings and vis versa.
However, we do not rule out the possibility that some
MDR phenotypes may arise in community settings.
ISEcp1 blaCMY-2 IS261.a
tnpA tnpR tnpM intI1 dfrA 5 IS26
Tn21 genes
tnpA tnpR tnpM intI1 dfrA7 qacEΔ1 sul1
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blaTEM- 52IS26 intI1 dfrA1 qacEΔ1 sul11.f
Figure 2 Schematic diagram illustrating examples of physical linkages amongst genetic elements and selected genes. 1a-1f: An
example of physical linkages between bla genes and multiple genetic elements such as integrons, ISEcp1, and IS26. 2a-2b: An example of
physical linkages between bla genes and ISEcp1. 3a-3d: An example of physical linkages between integrons and other genetic elements (such as
the ISCR1 element) that are in turn linked to bla genes and (fluoro)quinolone resistant genes. 4a-4c: An example of physical linkages between
Tn21 and integrons that are in turn be linked to IS elements. These illustrations are based on PCR mapping data and not sequencing. Therefore,
the sizes of each gene and the distances between any two genes are not drawn to scale.
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be due to their association with the Tn21 that contain a
complete set of transposition genes. Past studies show
that dfrA7 and dfrA1 cassettes associated with Tn21-
borne integrons are the most prevalent dfrA-subtypes in
Central, North and Western Africa [9-12]. In this study
however, the prevalence of dfrA7 was much lower than
that of dfrA1, dfrA12 and dfA17 in that order. The class
2 integron dfrA1/sat2/aadA1 array reported in this study
is globally distributed [13]. Our results may therefore re-
flect regional differences or similarities in distribution of
integron cassette arrays. Such differences may arise from
unique antimicrobial-use patterns in different countries.
This study also demonstrates an apparent correlation
between carriage of dfrA17 and resistance to multiple β-Table 5 Physical linkages between integrons and other genet
In
Type of integrons Total detected Tn7
Class 1 integrons with 3‘-CS 375 3 (1)
Class 1 integron with sul3 64 0
Class 1 integrons lacking 3’-CS or Sul3 25 0
Class 2 integron 3 3 (100)
Carriage of Tn21, Tn7 and IS elements among strains carrying class 1 integrons. Car
also shown.lactams as has been reported in Tunisia [12,14] and
from Northern Kenya among isolates from dog, cat and
human specimens [5]. The reasons behind these correla-
tions are yet to be elucidated. Carriage of different dfrA
sub-types in our isolates and carriage of multiple integron-
associated sul genes (sul1 and sul3) in the same isolate
possibly correlates to heavy usage of sulfonamides and tri-
methoprim in Kenya for treatment of different infections
and as prophylaxis against opportunistic infections among
people with HIV/AIDS [15-17].
Some integrons, especially those lacking the 3’-CS and
those containing a sul3 at the 3’-end, were linked to the
IS26 possibly because this element mediates deletion of
3’-CS in class 1 integrons 3’- terminal [18,19]. Similar re-
sults have been published in Australia, Spain and Nigeriaic elements
tegrons (number,%) physically linked to different elements
Tn21 ISCR1 ISEcp1 IS26
257 (69) 199 (53) 19 (5) 4 (1)
12 (19) 0 12 (19) 48 (75)
5 (20) 0 10 (40) 20 (80)
1 (33) 1 (33) 1 (33) 0
riage of other genetic elements among strains carrying class 2 integrons is
Table 6 Carriage of transposition genes among Tn21 transposons
Number (%) of Tn21 transposition gene combination
Category of Tn21 Number of Tn21 detected tnpA + tnpM only tnpR + tnpM only tnpM + tnpA + tnpR
Tn21 linked to integrons 156 0 9 (6) 147 (94)
Tn21 not linked to integrons 133 56 (42) 63 (47) 14 (11)
PCR methods were used for screening for three genes that are crucial for transposition of Tn21. The tnpA encodes a Tn21-like transposase, the tnpM encodes a
putative transposition regulator. Integrons are incorporated into the Tn21 framework adjacent to the tnpM gene. The tnpR encodes a resolvase.
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ing IS26-associated integrons are highly MDR probably
because the IS26 is also linked to other non-integron
genes such as β-lactamases.
Most β-lactamases, particularly those encoding CTX-M
-14 and −15 and CMY-2, were physically linked to ISEcp1.
Similar reports have been published in Tunisian [20,21]
but no ISEcp1 was detected upstream the bla-CTX-M-1
among our isolates as reported in a related study from the
same country [22]. In one isolate, this element was found
upstream the blaCTX-M-9. Reports of ISEcp1-blaCTX-M-9
linkages are rare but such linkages have been reported in
Klebsiella pneumoniae isolates in Taiwan [23]. Majority
of blaTEM genes, blaTEM-52 in particular, were physicallyTable 7 Analysis for physical association between bla
genes and various genetic elements
Number (%) of β-lactamase physically
linked to various genetic elements
β-lactamase
genes
Number of
isolates tested
IS26 ISEcp1 ISCR1 Integrons
blaSHV-1 60 23 (38) 12 (20) 10 (17) 9 (15)
blaOXA-1 43 12 (28) 21 (49) 32 (74) 36 (84)
blaOXA-2 17 0 2 (12) 5 (29) 3 (18)
blaSHV-5 18 10 (55) 5 (28) 3 (17) 1 (6)
blaSHV-12 19 7 (37) 4 (21) 3 (16) 2 (11)
blaCTX-M-1 9 1 (11) 0 2 (22) 1 (11)
blaCTX-M-3 15 6 (40) 0 0 0
blaCTX-M-8 6 2 (33) 1 (17) 0 0
blaCTX-M-9 3 0 1 (33) 3 (100) 0
blaCTX-M-14 25 10 (40) 3 (12) 5 (20) 3 (12)
blaCTX-M-15 32 4 (13) 30 (94) 0 0
blaTEM-103 18 2 (11) 0 1 (6) 1 (6)
blaTEM-109 9 0 0 0 0
blaTEM-50 10 2 (20) 1 (10) 6 (60) 3 (30)
blaTEM-52 37 29 (78) 1 (3) 3 (8) 2 (5)
blaTEM-78 9 2 (22) 0 3 (33) 2 (22)
blaTEM-125 36 3 (8) 0 3 (8) 2 (6)
blaTEM-152 14 1 (7) 0 4 (29) 2 (14)
blaTEM-158 10 1 (10) 0 0 0
blaCMY-2 48 12 (25) 42 (88) 12 (25) 3 (6)
Analysis for physical linkages between bla genes and various genetic
elements. The bla content of the isolates analyzed had been determined in a
past study [3].linked to the IS26 as reported in Belgium and Germany
[24,25]. Taken together, these results suggest that most
bla genes in our isolates are in similar genetic environ-
ments as those reported globally but the genetic environ-
ment of blaCTX-M-9 and blaCTX-M-1 in our isolates appears
to be different from those reported globally.
Our results further demonstrated that most bla genes
are distantly linked to elements that are in turn linked to
other resistance genes such as aac(6’)-lb-cr and qnr.
Similar reports have been published in Tunisia [20,21]
and in Nigeria [11]. ISEcp1, IS26 and ISCR1 are known
to mediate transposition and/or expression of multiple
resistance genes in their close proximity [26-31]. Car-
riage of such multiple elements, each carrying a set of
resistance genes may be responsible for the observed co-
resistance to multiple antimicrobials among our isolates.
Conjugation experiments confirmed that multiple ele-
ments were borne on narrow host-range plasmids such
as IncFII, IncH12 or on broad host-range plasmids such
as IncL/M. The type of conjugative plasmids in our iso-
lates (especially those carrying plasmids containing incF-
type, incHI2 and incI1 incL/M replicons) were shown
to confer resistances similar to those in strains from
Tunisia, [32] and from two other studies conducted in
Kenya [1,5]. We hypothesis that plasmids of different in-
compatibility groups have acquired similar or identical
sets of resistance genes and this acquisition is mediated
by genetic elements such as those investigated in this
study. Therefore, there is a possibility that such elements
act as genetic shuttles between plasmids of different in-
compatibility grouping. The similarities and differences
in genetic environments of bla, aac (6’)-lb-cr and qnr
genes reported in this study may reflect a difference in
transposition activities of such elements. We further
hypothesize that differences in antibiotic use patterns in
different regions influence the transposition activity of
such elements.
Conclusions
This study reports carriage of multiple genetic elements
in MDR E. coli strains and their association with selected
resistance genes. Strains carrying such elements are
likely to be well adapted to survive deleterious effects of
combined antimicrobial therapy. Furthermore, such MDR
strains have a potential to increase morbidity and mortal-
ity among patients. It is therefore important to launch
Table 8 Carriage of aac(6')-lb-cr and qnr genes among strains containing genetic elements and bla genes
Number (%) of strains carrying each gene and number
(%) of strains containing genes linked to genetic elements
Occurrence in strains
carrying bla genesa
Total Strains
containing
intI1
Linked
to intI1
Strains
containing
IS26
Linked
to IS26
Strains
containing
ISCR1
Linked
to ISCR1
Strains
containing
ISEcp1
Linked
to ISEcp1
β-lactamase
negative
strains
Strains
containing
TEM-1 or
SHV-1 only
Strains
containing
broad-spectrum
bla genes
aac(6’)-lb-cr 42 42 (100) 42 (100) 6 (14) 4 (9) 12 (29) 6 (14) 11 (26) 4 (10) 0 4 (9) 38 (91)
qnrA 34 27 (79) 26 (75) 11 (32) 4 (12) 28 (82) 23 (68) 8 (24) 1 (3) 0 2 (6) 32 (94)
qnrB 19 19 (100) 11 (58) 10 (53) 2 (11) 13 (64) 4 (21) 12 (63) 1 (5) 0 1 (5) 18 (95)
Table shows the number of isolates carrying the three (fluoro)quinolone resistance genes and the proportion of such strains in which these genes were physically linked to various genetic elements and to bla genes.
a: Distribution of the aac(6’)-lb-cr and qnr genes among strains fully susceptible to β-lactams, among those resistant to TEM-1 or SHV-1 with a narrow substrate-range and among those carrying genes encoding broad-
spectrum β-lactamases such as blaSHV-5, blaSHV-12, blaCMY and blaCTX-Ms.
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Table 9 Horizontal transfer of genetic elements and associated resistance genes from clinical strains (donors) to E. coli J53 (recipient)
Resistance profiles among donor and transconjugants
Resistance to selected antimicrobials among donors Physically linked genetic elements or resistance genes
detected in donors and recipients
Other genes whose linkages were
not determined
Plasmid replicons detected
AMP, CTX, CAZ, FOX, NA, CIP, TET, C, AMC, K, CN, SUL ISEcp1/blaCMY-2/IS26 aadA1, blaSHV-12 P, I1
AMP, CTX, CAZ, FOX, NA, CIP, TET, C, AMC, K, CN, SUL IS26/ISEcp1/blaCMY-2, qnrA1 Tn21, dfrA5, sul1 L/M
AMP, CTX, CAZ, NA, TET, C, AMC, K, CN, SUL, TRIM IS26/ISEcp1/blaCTX-M-15 Tn21, dfrA1, aac(6’)lb FII, F, A/C
AMP, CTX, CAZ, NA, TET, C, AMC, K, CN, SUL, TRIM IS26/ISEcp1/blaCTX-M-14 Tn21, aadA5, sul1, blaTEM-1 A/C, K, B/O
AMP, CTX, CAZ, NA, TET, C, AMC, K, CN, SUL, TRIM IS26/blaCTX-M-3/IS26 aac(6’)lb, qnrB FII, F
AMP, CTX, CAZ, NA, TET, C, AMC, K, CN, SUL, TRIM IS26/blaTEM-52/intI1/dfrA1/qacEΔ1/sul1 blaTEM-1 I1, FIB
AMP, CTX, CAZ, NA, CIP, TET, C, AMC, K, CN, SUL, TRIM ISEcp1/blaCTX-M-15 dfrA12, aadA1, blaOXA-1 blaTEM-1, sul3 XI
AMP, CTX, CAZ, FOX, NA, CIP, TET, C, AMC, K, CN, SUL ISEcp1/blaCMY-2/intI1/aac(6')-lb-cr/ISCR1/qnrA1 aac(6’)lb, catB3, dfrA1 L/M, K
AMP, CTX, CAZ, NA, CIP, TET, C, AMC, K, CN, SUL, TRIM intI1/dfrA16/aadA2/qacEΔ1/sul1/ISCR1/blaCTX-M-9 blaTEM-1, blaSHV-5 L/M
AMP, CTX, CAZ, NA, CIP, TET, C, AMC, K, CN, SUL, TRIM intI1/dfrA12/orfF/aadA2/qacEΔ1/sul1/ISCR1/qnrA/qacEΔ1/sul1 blaCTX-M-15, blaTEM-1, blaOXA-1 I1, FIB
AMP, CTX, CAZ, FOX, NA, CIP, TET, C, AMC, K, CN, SUL intI1/aadA2/qacEΔ1/sul1/ISCR1/blaCMY-2/qacEΔ1/sul1/ISCR1/ qnrA1, I1, K, B/O
AMP, CTX, CAZ, NA, CIP, TET, C, AMC, K, CN, TRIM SUL intI1/aac(6')-lb-cr/qacEΔ1/sul1/qnrA1/qacEΔ1/sul1 blaTEM-1, blaSHV-5 FIA, FIB
AMP, CTX, NA, CIP, TET, C, AMC, K, CN, SUL, TRIM Tn21/intI1/dfrA5/IS26 blaTEM-125 FIB, F, HI2
AMP, CTX, NA, CIP, TET, C, AMC, K, CN, SUL, TRIM Tn21/intI1/dfrA7/qacEΔ1/sul1 blaCTX-M-8, I1, F
AMP, CTX, CAZ, NA, CIP, TET, C, AMC, K, CN, SUL, TRIM Tn21/intI1/dfrA1/qacEΔ1/sul1 blaTEM-15, blaTEM-1, blaOXA-1, aac(6')-lb-cr FIB, HI2
Table shows carriage of genetic elements and selected genes conferring resistance to important classes of antimicrobials. The resistance phenotype and the genetic elements or genes transferred to the
transconjugants are indicated in bold.
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Table 10 Primers for screening for genetic elements and resistance genes and for analysis for physical linkages among
such elements and selected resistance genes
Target Gene/region Primer name 5'-3' sequence Annealing
Temperature
Expected product
size (bp)
Gene accession
Number
Integrons
intI1 INT-1 F GTTCGGTCAAGGTTCTG 50 923 U12338
INT-1R GCCAACTTTCAGCACATG
intI2 INT-2 F ATGTCTAACAGTCCATTTT 50 450 AJ001816.1
INT-2R AAATCTTTAACCCGCAAAC
intI3 INT3-F GCAGGGTGTGGACGAATACG 57 760 AY219651
INT3-R ACAGACCGAGAAGGCTTATG
3'-CS qacED1 ATCGCAATAGTTGGCGAAGT 56 800 X15370
sul1-B GCAAGGCGGAAACCCGCGCC X12869
integron class 1 VCR In-F GGCATACAAGCAGCAAGC 52 Variable U12338
In-B AAGCAGACTTGACCTGAT
integron 2 VCR hep74 CGGGATCCCGGACGGCATGCACGATTTGTA 55 Variable EU780012
hep51 GATGCCATCGCAAGTACGAG AJ002782
IS elements
ISEcp1 ISEcp1-F GTT GCT CTG TGG ATA ACT TG 55 180 AJ242809
ISEcp1-R CCT AAA TTC CAC GTG TGT
ISCR1 ISCR1-F CGC CCA CTC AAA CAA ACG 55 469 L06418
ISCR1-R GAG GCT TTG GTG TAA CCG
IS26 IS26-F GCGGTAAATCGTGGAGTGAT 55 704 NC 007941.1
IS26-R ATTCGGCAAGTTTTTGCTGT
Tn21 and Tn7
tnpM of Tn21 TnpM-F TCAACCTGACGGCGGCGA 55 348 AF071413
TnpM-R GGAGGTGGTAGCCGAGG
tnpR of Tn21 TnpR-F GTC AGC AGC TTC GAC CAG AA 62 500 NC 002134.1
TnpR-R GAG GTA CTG GTA GAG GGT TT
tnpA of Tn21 TnpA21-F TGC GCT CCG GCG ACA TCT GG 62 1200 NC 002134.1
TnpA21-R TCA GCC CGG CAT GCA CGC G
tnpA of Tn7 TnA7-F CCCAGCAATAAAAGAGCTCATTGAGCAAGC 55 738 FJ914220.1
TnA7-R TATCTAGAAACAGAGTGTCTTG
(fluoro)quinolone resistance genes
qnrA qnrA-F TTCAGCAAGAGGATTTCTCA 55 627 AY070235
qnrA-R GGCAGCACTATTACTCCCAA
qnrB qnrB-F CCTGAGCGGCACTGAATTTAT 60 408 DQ351241
qnrB-R GTTTGCTGCTCGCCAGTCGA
qnrS qnrS-F CAATCATACATATCGGCACC 60 641 AB187515
qnrS-R TCAGGATAAACAACAATACCC
aac(6′)-Ib-cr aac(6′)-Ib-cr-F TTGCGATGCTCTATGAGTGGCTA 55 482 AAL93141.1
aac(6′)-Ib-cr-R CTCGAATGCCTGGCGTGTTT
aac(6′)-Ib-cr (sequencing) CGTCACTCCATACATTGCAA
bla genes
blaTEM TEM-F ATGAGTATTCAACAT TTC CG 55 840 EF125012
TEM-R CCAATGCTTAATCAG TGA GG
Kiiru et al. BMC Microbiology 2013, 13:109 Page 11 of 14
http://www.biomedcentral.com/1471-2180/13/109
Table 10 Primers for screening for genetic elements and resistance genes and for analysis for physical linkages among
such elements and selected resistance genes (Continued)
blaSHV SHV-F TTCGCCTGTGTATTATCTCCCTG 50 854 AF148850
SHV-R TTAGCGTTGCCAGTGYTCG
blaCTX-M CTX-M-F ATGTGCAGYACCAGTAARGTKATGGC 60 593 Y10278
CTX-m-R TGGGTRAARTARGTSACCAGAAYCAGCGG
blaCMY CMY-F ATGATGAAAAAATCGTTATGC 55 1200 U77414
CMY-R TTGCAGCTTTTCAAGAATGCGC
blaOXA-1 OXA-1 F ATGAAAAACACAATACATATCAACTTCGC 62 820 JO2967
OXA-1R GTGTGTTTAGAATGGTGATCGCATT
blaOXA-2 OXA-2 F ACGATAGTTGTGGCAGACGAAC 62 602 AF300985
OXA-2R ATYCTGTTTGGCGTATCRATATTC
Primers used for screening various genetic elements and for interrogating physical linkages between different genetic elements and between such elements and
bla genes or (fluoro)quinolone resistance genes.
Y = T or C, R = G or A, S = G or C, K = G or T.
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http://www.biomedcentral.com/1471-2180/13/109surveillance programs and to put up measures to curtail
the spread of these highly resistant strains. There is also a
need to compare the genomes of strains encountered in
Africa with those from other parts of the world.
Methods
Isolates
The 1327 non-duplicate isolates were obtained sequen-
tially from 13 healthcare facilities in Kenya between
1992 and 2011 (19-year period) from 654 hospitalized
and 673 non-hospitalized patients. These isolates com-
prised of 451 strains from patients with urethral tract in-
fections (UTI) and those with urinary catheters while
371 were from blood of patients with septicemia. An-
other 505 strains were from fecal specimens of patients
with loose stool, watery and bloody diarrhea. Only one
isolate per specimen per patient was included for further
analysis. Among the isolates investigated in this study,
912 had been analyzed for bla genes in a a past study [3]
while 27 had been analyzed for selected genetic elements
[1]. Ethical clearance to carry out this study was
obtained from the KEMRI/National Ethics Committee
(approval number SSC No. 1177).
Antimicrobial susceptibility profiles
Susceptibility profiles for all isolates were determined using
antibiotic discs (Cypress diagnostics, Langdorp, Belgium)
on Mueller Hinton agar (Oxoid, Louis, Mo. USA) using
the Laboratory Standards Institute guidelines (CLSI) [33].
Detection of genetic elements
Figure 1 illustrates the strategy used for detection and
characterization of integrons and transposons. Detection
of class 1, 2 and 3 and determination of carriage of 3’-
conserved sequences (3’-CS) in class 1 integrons was
done as described before [34,35]. Class 1 integron vari-
able cassette region (VCR), the region in which theresistance gene cassettes are integrated, was amplified as
previously described by Dalsgaard et al. [35] while that
of class 2 integrons was amplified as described by White
et al. [36]. The VCRs of integrons lacking the typical 3’-
CS was determined using a PCR walking strategy pub-
lished before [37]. Identification of integron cassette
identity was done using a combination of restriction
fragment length polymorphism (RFLP), sequencing and
published bioinformatics tools [38,39]. Detection of the
ISEcp1, ISCR1, Tn21 and Tn7 elements was done as de-
scribed in published studies [34,35]. Analysis for Tn21
transposition genes:- tnpA, tnpR and tnpM genes was
done as previously described by Pearson et al. [40]. The
primers used in this study are presented in Table 10.
Detection of aac(6’)-lb-cr and qnr genes
Screening for aac(6′)-Ib-cr gene that confers cross-
resistance to fluoroquinolones and aminoglycoside was
done using a combination of PCR, RFLP and sequencing
as described by Park et al. [41]. The isolates were also
screened for genes conferring resistance to quinolones:
- qnrA, qnrB and qnrS using PCR and sequencing strat-
egies previously described by Wu et al. [42].
Interrogation for physical linkages between genetic
elements and resistance genes
Physical linkages between integron and the transposons
were determined using a combination of published pri-
mers targeting 5’-conserved sequences (5’-CS) of class 1
integrons and those targeting the tnpM of Tn2 or those
specific for tnpA7 of Tn7, Figure 1. A combination of
primers targeting IS elements and those targeting the 5’-
CS or the 3’-termini of integrons were used for interro-
gation for physical linkages between integrons and IS
elements. A combination of primers specific for various
genetic elements and consensus primers for blaSHV or
blaTEM, [43,44], blaCTX-M [45], blaCMY [46] and blaOXA
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between bla genes and different genetic elements. Primers
for aac(6’)-lb-cr and qnr genes were used in combination
with those for different genetic elements to analyze for their
physical association. A long-range polymerase [LongAmpW
Taq DNA Polymerase, (New England Biolabs, USA)] was
used in all reactions for physical linkages. A slow ramping
rate of between 0.2°C/sec and 0.3°C/sec was set for the
annealing step. The extension time was set at 72°C for
2 min and a final extension of 72°C for 15 min was carried
out after 35–40 cycles of denaturation, annealing and
extension.
Conjugation experiments
Conjugation experiments using sodium azide resistant E.
coli strain J53 as the recipient were done as previous de-
scribed [49]. Susceptibility to antimicrobials and determi-
nation of genetic element content of the transconjugants
was determined using similar methods as those used for
the corresponding donor strains. Plasmid incompatibility
groupings were determined using the scheme of Carattoli
et al. [50].
Statistical analysis
For the purpose of analysis, both intermediate and resist-
ant results for antibiotic susceptibility testing were
grouped together as “resistant”. Differences in proportion
of isolates bearing different elements was analyzed using
the Chi test (χ2) while the Fisher’s exact test was used for
smaller sample sizes. The Odds Rations (OR) and the 95%
confidence intervals (CIs) accompanying the χ2 tests were
determined using the approximation of Woolf. The null
hypothesis was rejected for values of p ≥ 0.05. Statistical
analysis was performed using Statgraphics plus Version 5
(StatPoint Technologies, INC, Warrenton, VA, USA).
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